共 50 条
- [31] Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trialJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 485 - 493Merola, Joseph F.Parish, Lawrence CharlesGuenther, LynLynde, CharlesLacour, Jean -PhilippeStaubach, PetraCheng, SueParis, MariaPicard, HernanDeignan, CynthiaJardon, ShaunaChen, MindyPapp, Kim A.
- [32] Methotrexate vs. ciclosporin in psoriasis:: effectiveness, quality of life and safety.: A randomized controlled trialBRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (01) : 116 - 121Flytstrom, I.Stenberg, B.Svensson, A.Bergbrant, I-M.
- [33] Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical TrialJAMA DERMATOLOGY, 2019, 155 (10) : 1153 - 1161Terui, TadashiKobayashi, SatomiOkubo, YukariMurakami, MasamotoZheng, RichuanMorishima, HitomiGoto, RyosukeKimura, Takayuki
- [34] Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naive patients with psoriasisJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (04) : 740 - 746Armstrong, April W.Betts, Keith A.Sundaram, MuraliThomason, DarrenSignorovitch, James E.
- [35] Efficacy of Leflunomide Compared to Methotrexate in the Treatment of Moderate to Severe Plaques Psoriasis: A Randomized Controlled Clinical TrialDERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (03):Aboelwafa, Hany OthmanMohamed, Hassan Abou KhodairIbrahim, Doaa MamdouhBedair, Nermeen Ibrahim
- [36] Optimizing adalimumab treatment in psoriasis with concomitant methotrexate: a randomized controlled trialJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 25 - 26Van der Kraaij, G.Busard, C.van den Reek, J.Menting, S.de Jong, E.de Kort, W.Lambert, J.Spuls, P.
- [37] Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) : 1387 - 1399Paul, C.Cather, J.Gooderham, M.Poulin, Y.Mrowietz, U.Ferrandiz, C.Crowley, J.Hu, C.Stevens, R. M.Shah, K.Day, R. M.Girolomoni, G.Gottlieb, A. B.
- [38] Efficacy and safety of apremilast with or without topical or phototherapy: Subanalysis of the population with < PASI-75 in the ESTEEM 1 phase 3, randomized, controlled trial in patients with moderate to severe plaque psoriasisJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB246 - AB246Reich, KristianKircik, LeonParis, MariaBagel, Jerry
- [39] Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialARTHRITIS & RHEUMATOLOGY, 2024, 76 (03) : 363 - 376Lend, KristinaKoopman, Frieda A.Lampa, JonJansen, GerritHetland, Merete L.Uhlig, TillNordstroem, DanNurmohamed, MichaelGudbjornsson, BjornRudin, AnnaOstergaard, MikkelHeiberg, Marte S.Sokka-Isler, TuulikkiHorslev-Petersen, KimHaavardsholm, Espen A.Grondal, GerdurTwisk, Jos W. R.van Vollenhoven, Ronald
- [40] Safety and efficacy profile of oral cyclosporine vs oral methotrexate vs oral acitretin in palmoplantar psoriasis: A hospital based prospective investigator blind randomized controlled comparative studyDERMATOLOGIC THERAPY, 2021, 34 (01)Shah, SamkitNikam, BalkrishnaKale, MohanJamale, VarshaChavan, Dhananjay